They don't increase your odds of living longer.

A review of 10 major statin
studies showed the same number of deaths and adverse effects in groups taking statins and not taking
statins. In order to prevent one heart attack or stroke, 71 people needed to take statins for 3 to 5
years. Despite this slight (1.4%) benefit, longevity was not increased in the statin group.

There has never been benefit shown for
many groups.

However benefit to survival with statins or other cholesterol-lowering agents
has never been demonstrated in women (even those at high cardiac
risk), in the older elderly, or in men at lower cardiac risk . . .[emphasis added]

Statins deplete the body of Coenzyme Q10 (Ubiquinone or CoQ10).

Statins work by interrupting the biosynthesis of cholesterol. They also interrupt the biosynthesis
of CoQ10. Widely available as a supplement, CoQ10 is needed by every cell of the body
for energy production. It is a potent anti-oxidant and is especially important for the heart muscle.

As with HRT, there are no long-term studies of the effects of statins. Statins may have the following adverse effects:

Polyneuropathy, including fatigue, loss of muscle function
or feeling in the muscle, difficulty walking or using the arms or feet, and sensation change,
including pain, burning, tingling, numbness or decreased sensation. These symptoms may be
progressive or recurrent.

. . . to form the sexual hormones --
no cholesterol, no sexual hormones, no humans. . . . to form the adrenal hormones (including
cortisol) that deal with stress and regulate glucose. . . . to maintain cell wall integrity in
every cell of the body. . . . for proper brain functioning --the brain has the largest
concentration of cholesterol in the body.

A few
quotes regarding statins . . .

Statins & Overall Mortality

"Do Statins Have a Role in Primary Prevention" is a review of 10 major statin trials conducted by
the Therapeutics Initiative of the Department of Pharmacology & Therapeutics of the University
of British Columbia. Here are their conclusions:

"If cardiovascular serious adverse events are viewed in
isolation, 71 primary prevention patients with cardiovascular risk factors have to be treated with a
statin for 3 to 5 years to prevent one myocardial infarction or stroke."

"This
cardiovascular benefit is not reflected in 2 measures of overall health impact, total mortality and
total serious adverse events. Therefore, statins have not been shown to provide an
overall health benefit in primary prevention trials." [emphasis added]

Statins & Coenzyme Q10 (Ubiquinone or CoQ10)

"A Significant decrease in plasma CoQ10 levels in patients treated with Mevacor and other
statins has been observed in short-term clinical trials. The clinical significance of a potential
long-term statin-induced deficiency of CoQ10 has not yet been established."

"Ubiquinone in a slightly altered form known as ubiquinol is found in all membranes where it has a vital function in maintaining membrane integrity. Compromise of this important role is thought to be involved both in muscle cell breakdown and nerve conduction defects associated with statin drug use"

Statins &
Polyneuropathy

"The authors note that their study showed that long-term exposure to
statins may substantially increase the risk of polyneuropathy. These findings suggest that statins
may have a toxic effect on peripheral nerves. One possible mechanism may be that by interfering with
cholesterol synthesis, statins may alter nerve membrane function."

Statins & Brain Function

"Total Global
Amnesia, once so rare that most physicians have never seen a case in their entire careers, is now
quite common in our emergency rooms associated with simply being on a statin drug. But amnesia is
only the tip of the iceberg. For every amnesia case report there are hundreds if not thousands of
cases of confusion and severe memory disturbance associated with being on statin drugs."

NOTE:
The highest concentration of cholesterol in the body is found in the brain and nervous system.

FDA as Protector

"Watchover [a program of the FDA] was informed of each Baycol [a
statin drug] death as it occurred during these past two years but bureaucratic inertia allowed over
fifty fatalities to occur before action was taken placing the credibility and effectiveness of FDA
in serious question."